Nayak, L., Hays, J., Muzikansky, A., Gaffey, S., Do, K., Hilton, J., . . . Reardon, D. (2015). ATNT-18 A PHASE I STUDY OF MLN0128 AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA AND OTHER SOLID TUMORS. Neuro Oncol.
Chicago-stil citatNayak, Lakshmi, et al. "ATNT-18 A PHASE I STUDY OF MLN0128 AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA AND OTHER SOLID TUMORS." Neuro Oncol 2015.
MLA-referensNayak, Lakshmi, et al. "ATNT-18 A PHASE I STUDY OF MLN0128 AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA AND OTHER SOLID TUMORS." Neuro Oncol 2015.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.